CASP2 and exocrine pancreatic carcinoma: It was shown that in human pancreatic carcinoma cells bortezomib disrupted lysosomes with release of cathepsin B to the cytosol where it cleaved caspase-2 and induced mitochondrial apoptotic pathway [32].